Form 4 for CGEN COMPUGEN LTD
Accepted 2026-04-27 16:02:06 ET · period of report 2026-04-24 · accession 0001178913-26-002243 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-04-27 16:02 | 2026-04-24 | CGEN | Ophir Eran | Pres, CEO, Dir | M - OptEx | $0.8292 | +5,000 | 16.4K | +44% | +$4,146 |
| DT | 2026-04-27 16:02 | 2026-04-24 | CGEN | Ophir Eran | Pres, CEO, Dir | S - Sale+OE | $3.20 | -5,000 | 11.4K | -31% | -$16.0K |
| DT | 2026-04-27 16:02 | 2026-04-24 | CGEN | Ophir Eran | Pres, CEO, Dir | M - OptEx | $0.00 | -5,000 | 14.4K | -26% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-04-24 | M | A | 5,000 | $0.8292 | 16,375 | D | — | — | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025. |
| 2 | Common | Ordinary Shares | 2026-04-24 | S | D | 5,000 | $3.20 | 11,375 | D | — | — | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025. (F2) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.20 to $3.205 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Derivative | Share Option (right to buy) | 2026-04-24 | M | D | 5,000 | $0.00 | 14,375 | D | $0.8292 · — to 2032-11-09 | 5,000 Ordinary Shares | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025. (F3) This option vested 25% on December 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. |